Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS) | MicrobiomeTrials← Back to trialsNCT07364045
Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2029-03-30
Enrollment target: 104 participants Locations- Clinical Research Facility, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
Other microbiome trials you might be interested in
T2DM (Type 2 Diabetes Mellitus)
The goal of this clinical trial is to evaluate whether an evidence-based anti-inflammatory dietary intervention can redu…
Hefei, ChinaEst. completion Nov 2026
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036